profit from every $100 of sales.
$0$100
Chemed
$548.20-0.36% today
+22.9% in 1 year
1-year low $368.591-year high $552.72
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $26.79 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Chemed sold, what it kept, and what it did with the cash.
Sales went from $2.13 billion in 2022 to $2.53 billion in 2025, with $265 million of profit last year.
SalesProfit
Chemed handed back more cash to shareholders than it generated last year.
Buybacks $432M
Free cash flow 2025$325M
Bought back its own shares$432M
Paid as dividends$32M
Cash vs. debt$75M vs. $144M
Chemed vs. similar companies
Chemed grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Chemed | 26.8× · Fair price | ||
 Tenet Healthcare | 16.2× · Fair price | ||
 Solventum | 9.7× · Cheap | ||
 Encompass Health | 24.4× · Fair price | ||
 Fresenius Medical Care AG & Co. KGaA | 10.6× · Cheap |
AI analysis
An AI analyst reads Chemed's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 2,080 | 2,139 | 2,135 | 2,264 | 2,431 | 2,530 | |
| 701 | 770 | 765 | 799 | 854 | 823 | |
| 390 | 343 | 347 | 343 | 367 | 341 | |
| 455 | 411 | 393 | 414 | 464 | 422 | |
| 319 | 269 | 250 | 273 | 302 | 265 | |
| 19.48 | 16.85 | 16.53 | 17.93 | 19.89 | 18.34 | |
| 33.7% | 36.0% | 35.8% | 35.3% | 35.1% | 32.5% | |
| 18.7% | 16.0% | 16.3% | 15.1% | 15.1% | 13.5% | |
| 15.4% | 12.6% | 11.7% | 12.0% | 12.4% | 10.5% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 1,435 | 1,343 | 1,442 | 1,668 | 1,669 | 1,538 |
| Cash | 163 | 33 | 74 | 264 | 178 | 75 |
| Total debt | – | 324 | 247 | 139 | 141 | 144 |
| Total liabilities | 534 | 719 | 643 | 560 | 550 | 559 |
| 901 | 623 | 799 | 1,108 | 1,119 | 979 | |
| 16 | 16 | 15 | 15 | 15 | 14 | |
| 34.9% | 29.4% | 25.3% | 22.4% | 25.2% | 25.1% | |
| 35.4% | 43.1% | 31.3% | 24.6% | 27.0% | 27.1% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 489 | 309 | 310 | 330 | 417 | 388 | |
| 59 | 59 | 57 | 57 | 50 | 63 | |
| 430 | 250 | 253 | 273 | 368 | 325 | |
| Dividends paid | 21 | 22 | 22 | 24 | 27 | 32 |
| 176 | 576 | 115 | 68 | 361 | 432 | |
| – | – | 26 | 30 | 32 | 33 |
Valuation
- 26.8×
- 22.5×
- –
- 6.8×
- 2.8×
- 21.8×
- 17.0×
- 4.6%
- 3.7%
- 0.5%
Profitability
- 32.5%
- 13.5%
- 10.5%
- 16.3%
- 19.5%
- 24.2%
- 25.3%
- 16.9%
- 27.0%
- –
Growth
- +4.0%
- −1.2%
- −11.5%
- +10.8%
- −2.1%
Financial health
- 0.5×
- 0.28
- 15.4%
- 94.4×
- 0.85
- 0.83
- 1.65
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 9%of 946
Top 39%of 871
Top 46%of 563
Bottom 24%of 867
Top 23%of 986
What analysts expect
- Average price target
- $475.00
- Range
- $475.00 – $475.00
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 23, 2026 | 5.65 | 5.30 | +6.6% |
| Feb 25, 2026 | 6.42 | 7.02 | −8.5% |
| Oct 28, 2025 | 5.27 | 5.39 | −2.2% |
| Jul 29, 2025 | 4.27 | 4.78 | −10.7% |
| Apr 23, 2025 | 5.63 | 5.55 | +1.4% |
| Feb 26, 2025 | 6.83 | 6.78 | +0.7% |
| Oct 29, 2024 | 5.64 | 5.76 | −2.1% |
| Jul 24, 2024 | 5.47 | 5.59 | −2.1% |
0.5%of the share price, paid each year
On $1,000 invested$5a year at today's yield, before tax
+10.8%2020 to 2025
Raised10 yearsin a row, in our data
Paid per share, each year
$0.92 in 2015 → $2.20 in 2025
How safe it looks
11.9% of its profit
Room to growStretchedMore than it earns: 9.7%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
3/7Passes 3 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
67Pass
Benjamin Graham
47No pass
Philip Fisher
53No pass
Peter Lynch
31No pass
Joel Greenblatt
38No pass
Charlie Munger
67Pass
Terry Smith
62Pass
Questions about Chemed
Is Chemed a good stock to buy?
A solid business at a fair price. 3 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Chemed AI analysis
What does Chemed do?
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It is in Medical - Care Facilities, based in Cincinnati, OH, United States, with 15,811 employees.
Does Chemed pay a dividend?
Yes. At today's price the dividend is 0.5% a year, about 12% of its yearly profit. In 2025 it paid out $31.7 million in dividends.
Is Chemed stock halal?
Yes. Chemed passes our halal screen: its business is permitted and its debt is 2% of its market value, under the 30% limit. How we check
How has Chemed stock done over the past year?
Up 22.9% over the past twelve months, to $548.20. It traded between $368.59 and $552.72, close to its high.
Who are Chemed's competitors?
The largest listed companies in the same industry are Tenet Healthcare, Solventum, Encompass Health and Fresenius Medical Care AG & Co. KGaA. The peers table on this page compares their profit, growth and price with Chemed's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.